Comprehensive Analysis of GINS Subunits Prognostic Value and CeRNA Network in Sarcoma

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2022 Sep 12

PMID 36092720

Authors

Chuqiao Zhou

Zhuoyuan Chen

Bo Xiao

Cheng Xiang

Aoyu Li

Ziyue Zhao

Hui Li

Affiliations

Soon will be listed here.

Abstract

The GINS complex, composed of GINS1/2/3/4 subunits, is an essential structure of Cdc45-MCM-GINS (CMG) helicase and plays a vital role in establishing the DNA replication fork and chromosome replication. Meanwhile, GINS genes have been associated with the poor prognosis of various malignancies. However, the abnormal expression of GINS genes and their diagnostic and prognostic value in sarcomas (SARC) remain unclear. Oncomine, Gene Expression Profiling Interactive Analysis (GEPIA), Kaplan-Meier Plotter, Cancer cell line encyclopedia (CCLE), The University of Alabama at Birmingham Cancer Data Analysis Portal (UALCAN), R studio, and Tumor Immune Estimation Resource (TIMER) were used to analyze the expression profiles, prognostic value, biological function, ceRNA, and immune infiltration associated with GINS genes in sarcomas. We found that GINS1/2/3/4 genes exhibited significantly upregulated transcription levels in SARC samples compared to non-tumor tissues and exhibited high expression levels in sarcoma cell lines. In addition, SARC patients with increased expression levels of GINS1/2/3/4 showed poorer survival rates. Immune infiltration analysis showed that GINS subunits were closely associated with the infiltration of immune cells in sarcomas. Our research identified GINS subunits as potential diagnostic and prognostic biological targets in SARC and elucidated their underlying effects in the genesis and progression of SARC. These results may provide new opportunities and research directions for targeted sarcoma therapy.

Citing Articles

In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene.

Kamal M, Mia M, Faruque M, Rabby M, Islam M, Talukder M Sci Rep. 2024; 14(1):11607.

PMID: 38773180 PMC: 11109216. DOI: 10.1038/s41598-024-62299-2.

Extracellular vesicle small RNA cargo discriminates non-cancer donors from pediatric B-lymphoblastic leukemia patients.

Longjohn M, Hudson J, Pena-Castillo L, Cormier R, Hannay B, Chacko S Front Oncol. 2023; 13:1272883.

PMID: 38023151 PMC: 10679349. DOI: 10.3389/fonc.2023.1272883.

Multi-omics analysis of the oncogenic role of optic in human cancer.

Wu Z, Xu N, Li G, Yang W, Zhang C, Zhong H Aging (Albany NY). 2023; 15(22):12982-12997.

PMID: 37980164 PMC: 10713406. DOI: 10.18632/aging.205214.

Comprehensive Analysis of Tumor Microenvironment Reveals Prognostic ceRNA Network Related to Immune Infiltration in Sarcoma.

Leng D, Yang Z, Sun H, Song C, Huang C, Ip K Clin Cancer Res. 2023; 29(19):3986-4001.

PMID: 37527025 PMC: 10543973. DOI: 10.1158/1078-0432.CCR-22-3396.

References

Yoshida M, Ishioka Y, Ozawa T, Okuyama H, Iguchi M, Ota T . Soluble HLA-associated peptide from PSF1 has a cancer vaccine potency. Sci Rep. 2017; 7(1):11137. PMC: 5593935. DOI: 10.1038/s41598-017-11605-2. View

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

Hu H, Ye L, Liu Z . GINS2 regulates the proliferation and apoptosis of colon cancer cells through PTP4A1. Mol Med Rep. 2022; 25(4). PMC: 8855163. DOI: 10.3892/mmr.2022.12633. View

Zou R, Xu H, Li F, Wang S, Zhu L . Increased Expression of Predicting Poor Survival of Epithelial Ovarian Cancer: Based on Comprehensive Analysis of , Clinical Samples, and the GEO Database. DNA Cell Biol. 2020; 40(1):36-60. DOI: 10.1089/dna.2020.5823. View

Gong Z, Kidoya H, Mohri T, Han Y, Takakura N . DNA damage enhanced by the attenuation of SLD5 delays cell cycle restoration in normal cells but not in cancer cells. PLoS One. 2014; 9(10):e110483. PMC: 4204874. DOI: 10.1371/journal.pone.0110483. View

Huber K, Mestres-Arenas A, Fajas L, Leal-Esteban L . The multifaceted role of cell cycle regulators in the coordination of growth and metabolism. FEBS J. 2020; 288(12):3813-3833. PMC: 8359344. DOI: 10.1111/febs.15586. View

Takayama Y, Kamimura Y, Okawa M, Muramatsu S, Sugino A, Araki H . GINS, a novel multiprotein complex required for chromosomal DNA replication in budding yeast. Genes Dev. 2003; 17(9):1153-65. PMC: 196052. DOI: 10.1101/gad.1065903. View

Parker M, Botchan M, Berger J . Mechanisms and regulation of DNA replication initiation in eukaryotes. Crit Rev Biochem Mol Biol. 2017; 52(2):107-144. PMC: 5545932. DOI: 10.1080/10409238.2016.1274717. View

Bleloch J, Ballim R, Kimani S, Parkes J, Panieri E, Willmer T . Managing sarcoma: where have we come from and where are we going?. Ther Adv Med Oncol. 2017; 9(10):637-659. PMC: 5613860. DOI: 10.1177/1758834017728927. View

10.

Scott E, Gocher A, Workman C, Vignali D . Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor Microenvironment. Front Immunol. 2021; 12:702726. PMC: 8222776. DOI: 10.3389/fimmu.2021.702726. View

11.

Tokar T, Pastrello C, Rossos A, Abovsky M, Hauschild A, Tsay M . mirDIP 4.1-integrative database of human microRNA target predictions. Nucleic Acids Res. 2017; 46(D1):D360-D370. PMC: 5753284. DOI: 10.1093/nar/gkx1144. View

12.

Seo Y, Kang Y . The Human Replicative Helicase, the CMG Complex, as a Target for Anti-cancer Therapy. Front Mol Biosci. 2018; 5:26. PMC: 5885281. DOI: 10.3389/fmolb.2018.00026. View

13.

Bu F, Zhu X, Yi X, Luo C, Lin K, Zhu J . Expression Profile of GINS Complex Predicts the Prognosis of Pancreatic Cancer Patients. Onco Targets Ther. 2020; 13:11433-11444. PMC: 7654543. DOI: 10.2147/OTT.S275649. View

14.

Ghandi M, Huang F, Jane-Valbuena J, Kryukov G, Lo C, McDonald 3rd E . Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature. 2019; 569(7757):503-508. PMC: 6697103. DOI: 10.1038/s41586-019-1186-3. View

15.

Rong Z, Luo Z, Zhang J, Li T, Zhu Z, Yu Z . GINS complex subunit 4, a prognostic biomarker and reversely mediated by Krüppel-like factor 4, promotes the growth of colorectal cancer. Cancer Sci. 2020; 111(4):1203-1217. PMC: 7156840. DOI: 10.1111/cas.14341. View

16.

Li S, Lian Y, Huang Y, Huang Y, Xiao J . Overexpressing PLOD family genes predict poor prognosis in gastric cancer. J Cancer. 2020; 11(1):121-131. PMC: 6930397. DOI: 10.7150/jca.35763. View

17.

Prieto L, Baker D . Cellular Senescence and the Immune System in Cancer. Gerontology. 2019; 65(5):505-512. PMC: 6703936. DOI: 10.1159/000500683. View

18.

Huang L, Chen S, Fan H, Ji D, Chen C, Sheng W . GINS2 promotes EMT in pancreatic cancer via specifically stimulating ERK/MAPK signaling. Cancer Gene Ther. 2020; 28(7-8):839-849. PMC: 8370876. DOI: 10.1038/s41417-020-0206-7. View

19.

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

20.

Tang L, Yu W, Wang Y, Li H, Shen Z . Anlotinib inhibits synovial sarcoma by targeting GINS1: a novel downstream target oncogene in progression of synovial sarcoma. Clin Transl Oncol. 2019; 21(12):1624-1633. DOI: 10.1007/s12094-019-02090-2. View